Abstract
The treatment of brain tumors including glioblastoma multiformes (GBMs) remains a challenge. The main option is still surgery to remove the bulk of the tumor and adjuvant treatments for the infiltrating parts. The blood brain barrier (BBB), however, restricts the access of chemotherapeutic agents to the tumor. The use of nanoparticle-based drug delivery systems (DDSs) has an increasing impact on disease diagnosis and therapy. By altering their size, composition, and surface chemistry, nanoparticles can be developed into a universal platform with multifunctional capabilities to meet the tunable requirements of different DDS. Thus, nanoparticles have the potential for targeted delivery of therapeutic cargo to brain tumors combined with simultaneous detection and imaging functions, providing a new strategy for effective therapy. The purpose of this article is to provide an updated review on the current progression and future possibilities of treating brain tumors with nanoparticles.
Keywords: Nanoparticles, targeted drug delivery, blood-brain barrier, imaging, therapy, Solid Brain Tumors, glioblastoma multiformes, drug delivery systems, convection-enhanced delivery, magnetic resonance imaging, retention (EPR), enhanced permeability, antineoplastic agents, central nervous system (CNS), non-cytotoxic, phospholipids, Antibody-directed Liposomes, Epider-mal growth factor receptor (EGFR), transmembrane tyrosine kinase, Doxorubicin, paclitaxel, Immunoliposomes, Boron Neutron Capture Therapy (BNCT), glioma cells, nickel-immunoliposomes, Immunohistochemical, Gaussia princeps luciferase, Liposomes in Gene Therapy, Polymeric Nanoparticles, Metallic Nanoparticles, Bionanocapsules, hepatitis B virus
Current Nanoscience
Title: Nanoparticle-based Drug Delivery Systems for Solid Brain Tumors
Volume: 7 Issue: 1
Author(s): Bin Feng, Hideki Matsui and Kazuhito Tomizawa
Affiliation:
Keywords: Nanoparticles, targeted drug delivery, blood-brain barrier, imaging, therapy, Solid Brain Tumors, glioblastoma multiformes, drug delivery systems, convection-enhanced delivery, magnetic resonance imaging, retention (EPR), enhanced permeability, antineoplastic agents, central nervous system (CNS), non-cytotoxic, phospholipids, Antibody-directed Liposomes, Epider-mal growth factor receptor (EGFR), transmembrane tyrosine kinase, Doxorubicin, paclitaxel, Immunoliposomes, Boron Neutron Capture Therapy (BNCT), glioma cells, nickel-immunoliposomes, Immunohistochemical, Gaussia princeps luciferase, Liposomes in Gene Therapy, Polymeric Nanoparticles, Metallic Nanoparticles, Bionanocapsules, hepatitis B virus
Abstract: The treatment of brain tumors including glioblastoma multiformes (GBMs) remains a challenge. The main option is still surgery to remove the bulk of the tumor and adjuvant treatments for the infiltrating parts. The blood brain barrier (BBB), however, restricts the access of chemotherapeutic agents to the tumor. The use of nanoparticle-based drug delivery systems (DDSs) has an increasing impact on disease diagnosis and therapy. By altering their size, composition, and surface chemistry, nanoparticles can be developed into a universal platform with multifunctional capabilities to meet the tunable requirements of different DDS. Thus, nanoparticles have the potential for targeted delivery of therapeutic cargo to brain tumors combined with simultaneous detection and imaging functions, providing a new strategy for effective therapy. The purpose of this article is to provide an updated review on the current progression and future possibilities of treating brain tumors with nanoparticles.
Export Options
About this article
Cite this article as:
Feng Bin, Matsui Hideki and Tomizawa Kazuhito, Nanoparticle-based Drug Delivery Systems for Solid Brain Tumors, Current Nanoscience 2011; 7 (1) . https://dx.doi.org/10.2174/157341311794480327
DOI https://dx.doi.org/10.2174/157341311794480327 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARγ Agonists?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Identification of Phosphoproteins and their Impact as Biomarkers in Cancer Therapeutics
Current Signal Transduction Therapy Phagoptosis - Cell Death By Phagocytosis - Plays Central Roles in Physiology, Host Defense and Pathology
Current Molecular Medicine Apoptosis-Inducing Effects of Amaryllidaceae Alkaloids
Current Medicinal Chemistry Brain-Derived Neurotrophic Factor (BDNF) has Proliferative Effects on Neural Stem Cells through the Truncated TRK-B Receptor, MAP Kinase, AKT, and STAT-3 Signaling Pathways
Current Neurovascular Research Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
Current Cancer Drug Targets Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)
Anti-Cancer Agents in Medicinal Chemistry Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Current Gene Therapy Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
Anti-Cancer Agents in Medicinal Chemistry The Application of Nanomaterials in Stem Cell Therapy for Some Neurological Diseases
Current Drug Targets Carbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
Current Medicinal Chemistry Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?
Current Medicinal Chemistry Design and Development of Glutathione Conjugated Poly (d, l) lactide Nanocarriers for Delivery of Hydrophilic Fluorescent Marker across Blood Brain Barrier
Current Nanoscience Proteomics and Epigenetic Mechanisms in Stem Cells
Current Proteomics IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future
Current Immunology Reviews (Discontinued) Meet Our Editorial Board Member
Current Drug Discovery Technologies Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Development of Decision Tree Models for Substrates, Inhibitors, and Inducers of P-Glycoprotein
Current Drug Metabolism